Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
iX Biopharma Ltd.

iX Biopharma Ltd. (42C.SI) Stock Overview

Explore iX Biopharma Ltd.’s financial performance, market position, analyst ratings, and future outlook.

42C.SI●SES
HealthcareDrug Manufacturers - Specialty & Generic
S$0.48
S$0.02(3.000%)
Singapore Market opens in 5h 21m

iX Biopharma Ltd. (42C.SI)

Meyka AI Score

Z

Key Financials

Market Cap530.3M
P/E Ratio-72.39
EPS (TTM)$-0.01
ROE-2.14%
Fundamental Analysis

AI Price Forecasts

1 Month$0.52
3 Months$0.58
1 Year Target$0.60

42C.SI Stock Analysis & Investment Overview (SES)

Our AI-powered analysis of iX Biopharma Ltd. (SES: 42C.SI) gives investors deep insight into how the stock performs on the SES exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, iX Biopharma Ltd.'s SES-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of 42C.SI on the SES shows an RSI of 53.19, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.60 for the SES listing.

Key metrics behind iX Biopharma Ltd.'s SES-traded stock include a P/E ratio of -72.39 and a market capitalization of 530.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of 42C.SI on the SES.

Price Performance (SES: 42C.SI)

1-Day Change
-3.00%
5-Day Change
-6.73%
1-Month Change
29.33%
3-Month Change
31.08%
6-Month Change
136.59%
Year-to-Date (YTD) Change
256.62%
1-Year Change
2452.63%
3-Year Change
931.91%
5-Year Change
110.87%
All-Time (Max) Change
-11.13%

Contact Information

https://www.ixbiopharma.com
65 6235 2270
No. 14-01 Great World City East Lobby, Singapore, CE, 237994

Company Facts

350 Employees
IPO DateJul 22, 2015
CountrySG
Actively Trading

Frequently Asked Questions